About Zimmer Biomet Holdings, Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.zimmerbiomet.com/en
Frequently Asked Questions
What is the 52-week range for ZBH?
The 52-week high is $106.88 and the 52-week low is $79.12.
What is the P/E ratio for ZBH?
The Price to Earnings (P/E) ratio is 21.34.
What is the dividend yield for ZBH?
The indicated annual dividend yield is 1.04%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 6.35%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 9.48%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.40.
Analyst Recommendation Trends
Wall Street analyst consensus for ZBH over the last few months:
Latest ZBH News
Are You Overpaying For Intuitive Surgical Stock Versus Its Rivals?
Intuitive Surgical (ISRG) grows faster and earns a higher operating margin than any of the five rivals in its health care peer group. It is also the most expensive of the six when price is measured against earnings. It holds that place even after its stock fell 10.3% over the past twelve months. How much more do you pay for a dollar of Intuitive's earnings than for a dollar of a rival's.
Do You Really Understand ISRG Stock's Risk?
Look at the breakdown of Intuitive Surgical's revenue streams—Instruments and Accessories alone generate roughly 60% of the top line on a per-procedure basis. That tight link between surgery volume and cash flow explains why investors reacted so sharply when Intuitive noted in its fiscal Q2 2026 call that U.S. procedure growth had slowed. With recurring earnings visibility clouded, how much downside risk is the market actually pricing in.
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is the giant, selling hospitals everything from hip and knee products to capital equipment. ResMed is a sleep device maker with less than a quarter of Stryker's revenue. Stryker costs 32.6 times its past year's earnings, against 21.9 times for ResMed. So does Stryker's reach justify that higher price? T
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings?
Zimmer Biomet currently trades at $91.50 per share and has shown little upside over the past six months, posting a middling return of 4.4%. The stock also fell short of the S&P 500’s 16.9% gain during that period.
Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value?
Zimmer Biomet Holdings: recent performance and context Zimmer Biomet Holdings (ZBH) has drawn investor attention after a stretch of weaker share performance, with the stock down 1.3% over the past day and 10.5% over the past month. At a share price of US$89.69, Zimmer Biomet Holdings has seen momentum fade recently, with the 30-day share price return down 10.5% and the 1-year total shareholder return declining 6.5%. This points to cooler sentiment following earlier periods of...
Can This Number Push ISRG Stock Higher?
Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year earlier. Most came from customers moving to the new da Vinci 5 robot. Those trade-ins matter most if upgrades continue and each surgery also earns more. Is that number a blip, or are customers still trading up.
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision procedures, and advances in AI-powered surgical, rehabilitation, radiosurgery, hospital, and pharmacy robots. Robotic systems will hold the largest market share, while surgical robots will lead by type. Ambulatory surgery centers are set for the fastest end-user growth, and Asi
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughly 760,000 people and claw back billions in subsidies.
These S&P500 stocks are moving in today's session
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System Market Minimally Invasive Robotic Surgical System Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Minimally Invasive Robotic Surgical System Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Minimally Invasive Robotic Surgical System Market to Reach $18.15 Bil
3 Mid-Cap Stocks with Open Questions
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.
How Far Could ISRG Stock Bounce From Here?
Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none of its visits to this price range turned into a 20% gain before a 5% drop.
Tracking William Nygren's Harris Associates Portfolio - Q2 2026 Update
Harris Associates' 13F portfolio rose to $75.42B in Q2 2026, with 30 core positions exceeding 1.25% each. Read more on the portfolio here.
Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story
Treace Medical outlook: revenue declines, Lapiplasty losing share, margins compressing, and EBITDA delayed. Click for more on TMCI stock.
Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
Intuitive Surgical (ISRG) has lost about 12% over the past year, while the S&P 500 returned about 17%. Most of the debate has been about the U.S. procedure growth slowing. The number that should worry a holder more is the money the company collects on the instruments used in each operation. Intuitive plans to lower it.
Is ISRG Stock Really As Expensive As It Looks?
Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings. That is normalized net income with stock-based compensation added back, a basis meant to sit closer to the one analysts forecast on, though the two are not defined identically. Analysts' forecasts run to 2027, the year Intuitive plans to start lowering what customers pay per use on some instruments.
Is Zimmer Biomet Stock Underperforming the Nasdaq?
As Zimmer Biomet has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain cautious about the stock’s prospects.
Get Paid To Wait For ISRG Stock To Go On Sale
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and you keep the payment either way. The catch is it only works if you would want this business at that price.
How Zimmer Biomet’s New Americas and Robotics Leadership Structure At Zimmer Biomet Holdings (ZBH) Has Changed Its Investment Story
Zimmer Biomet Holdings, Inc. recently announced a major reshuffling of its leadership structure, effective October 1, 2026, promoting Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data, while Group President Kevin Thornal exited on September 30, 2026. This overhaul elevates long-tenured internal leaders with deep orthopedic, robotics and commercial experience,...
Zimmer proposes to cut 580 jobs in Switzerland
Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.
Stryker: Operational Issues Have Created An Opportunity
Stryker's share price declined significantly due to operational issues, valuation concerns, and weaker orthopedic procedure volume growth. Learn more about SYK stock here.
3 Cash-Producing Stocks We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Zimmer restructures Americas leadership team
The company promoted three executives and eliminated a fourth position as part of changes intended to support its ongoing commercial transformation.
How Much Can ISRG Stock Still Move Against You?
Intuitive Surgical (ISRG) has handed its owners a hard year. The stock is down 25% over the trailing twelve months while the S&P 500 returned 19.3%, and it now trades about 41% below its 52-week high. After a fall like that the natural hope is that the big moves are behind you. Options priced a year out say they are not.
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced leadership appointments designed to streamline its Americas and Global Business Group organizations for greater focus and agility.
Zimmer Biomet Reiterates Its FY 2026 Financial Outlook
Zimmer Biomet also announced today that the Company is reiterating its full-year 2026 financial outlook provided on August 5, 2026.
Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
1 Profitable Stock to Keep an Eye On and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-11 | Thornal Kevin R | -5,691 | $92.95 | $528,978 |
| 2026-09-04 | Phipps Chad F | -3,000 | $98.35 | $295,050 |
| 2026-08-03 | Desai Chintan | +10,168 | - | - |
| 2026-08-01 | Thornal Kevin R | -9,957 | - | - |
| 2026-08-01 | Thornal Kevin R | -4,266 | $92.68 | $395,373 |
| 2026-08-01 | Thornal Kevin R | +9,957 | - | - |
| 2026-06-30 | Shapiro Louis | +159 | - | - |
| 2026-06-30 | Kurdikar Devdatt | +180 | - | - |
| 2026-06-30 | Kolli Sreelakshmi | +180 | - | - |
| 2026-06-30 | Hilado Maria Teresa | +389 | - | - |
| 2026-06-30 | Farrell Michael J. | +433 | - | - |
| 2026-06-30 | HAGEMANN ROBERT | +317 | - | - |
| 2026-06-30 | HIGGINS ARTHUR J | +317 | - | - |
| 2026-06-01 | Noor Jehanzeb | +1,857 | - | - |
| 2026-05-29 | Yi Sang | -800 | $82.66 | $66,128 |
| 2026-05-29 | Yi Sang | -4,200 | $82.64 | $347,088 |
| 2026-05-22 | Shapiro Louis | +1,517 | - | - |
| 2026-05-22 | Shapiro Louis | +875 | - | - |
| 2026-05-22 | Kurdikar Devdatt | +1,517 | - | - |
| 2026-05-22 | Kurdikar Devdatt | +875 | - | - |
| 2026-05-22 | Jafry Syed A. | +1,517 | - | - |
| 2026-05-22 | Jafry Syed A. | +875 | - | - |
| 2026-05-22 | Kolli Sreelakshmi | +1,517 | - | - |
| 2026-05-22 | Kolli Sreelakshmi | +875 | - | - |
| 2026-05-22 | Hilado Maria Teresa | +1,517 | - | - |
| 2026-05-22 | Hilado Maria Teresa | +875 | - | - |
| 2026-05-22 | Farrell Michael J. | +1,517 | - | - |
| 2026-05-22 | Farrell Michael J. | +875 | - | - |
| 2026-05-22 | HAGEMANN ROBERT | +1,517 | - | - |
| 2026-05-22 | HAGEMANN ROBERT | +875 | - | - |
| 2026-05-22 | BERNARD BETSY J | +1,517 | - | - |
| 2026-05-22 | BERNARD BETSY J | +875 | - | - |
| 2026-05-22 | HIGGINS ARTHUR J | +1,517 | - | - |
| 2026-05-22 | HIGGINS ARTHUR J | +875 | - | - |
| 2026-05-01 | Stellato Paul A | +9,232 | - | - |
| 2026-04-01 | Noor Jehanzeb | -6,626 | - | - |
| 2026-04-01 | Noor Jehanzeb | -1,677 | $90.67 | $152,054 |
| 2026-04-01 | Noor Jehanzeb | +6,626 | - | - |
| 2026-03-31 | Shapiro Louis | +154 | - | - |
| 2026-03-31 | Kurdikar Devdatt | +154 | - | - |
| 2026-03-31 | Jafry Syed A. | +182 | - | - |
| 2026-03-31 | Kolli Sreelakshmi | +175 | - | - |
| 2026-03-31 | Hilado Maria Teresa | +379 | - | - |
| 2026-03-31 | Farrell Michael J. | +421 | - | - |
| 2026-03-31 | HAGEMANN ROBERT | +309 | - | - |
| 2026-03-31 | HIGGINS ARTHUR J | +309 | - | - |
| 2026-03-12 | Winkler Lori | -2,650 | $94.66 | $250,849 |
| 2026-03-06 | VAN ZUILEN WILFRED | -2,161 | - | - |
| 2026-03-06 | VAN ZUILEN WILFRED | -4,843 | - | - |
| 2026-03-06 | VAN ZUILEN WILFRED | -562 | $92.54 | $52,007 |
| 2026-03-06 | VAN ZUILEN WILFRED | +2,161 | - | - |
| 2026-03-06 | VAN ZUILEN WILFRED | -1,260 | $92.54 | $116,600 |
| 2026-03-06 | VAN ZUILEN WILFRED | +4,843 | - | - |
| 2026-03-06 | Winkler Lori | -1,699 | - | - |
| 2026-03-06 | Winkler Lori | -3,935 | - | - |
| 2026-03-06 | Winkler Lori | -629 | $92.54 | $58,208 |
| 2026-03-06 | Winkler Lori | +1,699 | - | - |
| 2026-03-06 | Winkler Lori | -1,549 | $92.54 | $143,344 |
| 2026-03-06 | Winkler Lori | +3,935 | - | - |
| 2026-03-06 | Tornos Ivan | -5,438 | - | - |
| 2026-03-06 | Tornos Ivan | -4,830 | - | - |
| 2026-03-06 | Tornos Ivan | -24,436 | - | - |
| 2026-03-06 | Tornos Ivan | -3,008 | $92.54 | $278,360 |
| 2026-03-06 | Tornos Ivan | +5,438 | - | - |
| 2026-03-06 | Tornos Ivan | -2,671 | $92.54 | $247,174 |
| 2026-03-06 | Tornos Ivan | +4,830 | - | - |
| 2026-03-06 | Tornos Ivan | -13,516 | $92.54 | $1,250,771 |
| 2026-03-06 | Tornos Ivan | +24,436 | - | - |
| 2026-03-06 | Stellato Paul A | -607 | - | - |
| 2026-03-06 | Stellato Paul A | -1,363 | - | - |
| 2026-03-06 | Stellato Paul A | -282 | $92.54 | $26,096 |
| 2026-03-06 | Stellato Paul A | +607 | - | - |
| 2026-03-06 | Stellato Paul A | -633 | $92.54 | $58,578 |
| 2026-03-06 | Stellato Paul A | +1,363 | - | - |
| 2026-03-06 | Yi Sang | -2,364 | - | - |
| 2026-03-06 | Yi Sang | -7,050 | - | - |
| 2026-03-06 | Yi Sang | +2,364 | - | - |
| 2026-03-06 | Yi Sang | +7,050 | - | - |
| 2026-03-06 | Upadhyay Suketu | -4,559 | - | - |
| 2026-03-06 | Upadhyay Suketu | -10,217 | - | - |
| 2026-03-06 | Upadhyay Suketu | -2,029 | $92.54 | $187,764 |
| 2026-03-06 | Upadhyay Suketu | +4,559 | - | - |
| 2026-03-06 | Upadhyay Suketu | -4,547 | $92.54 | $420,779 |
| 2026-03-06 | Upadhyay Suketu | +10,217 | - | - |
| 2026-03-06 | Phipps Chad F | -2,094 | - | - |
| 2026-03-06 | Phipps Chad F | -4,692 | - | - |
| 2026-03-06 | Phipps Chad F | -843 | $92.54 | $78,011 |
| 2026-03-06 | Phipps Chad F | +2,094 | - | - |
| 2026-03-06 | Phipps Chad F | -1,889 | $92.54 | $174,808 |
| 2026-03-06 | Phipps Chad F | +4,692 | - | - |
| 2026-02-25 | Winkler Lori | -2,347 | - | - |
| 2026-02-25 | Winkler Lori | -924 | $99.51 | $91,947 |
| 2026-02-25 | Winkler Lori | +2,347 | - | - |
| 2026-02-25 | Yi Sang | -2,785 | - | - |
| 2026-02-25 | Yi Sang | +2,785 | - | - |
| 2026-02-25 | VAN ZUILEN WILFRED | -3,182 | - | - |
| 2026-02-25 | VAN ZUILEN WILFRED | -828 | $99.51 | $82,394 |
| 2026-02-25 | VAN ZUILEN WILFRED | +3,182 | - | - |
| 2026-02-25 | Tornos Ivan | -19,090 | - | - |
| 2026-02-25 | Tornos Ivan | -10,557 | $99.51 | $1,050,527 |
| 2026-02-25 | Tornos Ivan | +19,090 | - | - |
| 2026-02-25 | Stellato Paul A | -820 | - | - |
| 2026-02-25 | Stellato Paul A | -402 | $99.51 | $40,003 |
| 2026-02-25 | Stellato Paul A | +820 | - | - |
| 2026-02-25 | Upadhyay Suketu | -6,364 | - | - |
| 2026-02-25 | Upadhyay Suketu | -2,832 | $99.51 | $281,812 |
| 2026-02-25 | Upadhyay Suketu | +6,364 | - | - |
| 2026-02-25 | Phipps Chad F | -2,626 | - | - |
| 2026-02-25 | Phipps Chad F | -1,057 | $99.51 | $105,182 |
| 2026-02-25 | Phipps Chad F | +2,626 | - | - |
| 2026-02-20 | Noor Jehanzeb | +10,076 | - | - |
| 2026-02-20 | VAN ZUILEN WILFRED | +10,334 | - | - |
| 2026-02-20 | VAN ZUILEN WILFRED | -2,451 | - | - |
| 2026-02-20 | VAN ZUILEN WILFRED | -638 | $98.62 | $62,920 |
| 2026-02-20 | VAN ZUILEN WILFRED | +2,451 | - | - |
| 2026-02-20 | Winkler Lori | +7,880 | - | - |
| 2026-02-20 | Winkler Lori | -1,845 | - | - |
| 2026-02-20 | Winkler Lori | -683 | $98.62 | $67,357 |
| 2026-02-20 | Winkler Lori | +1,845 | - | - |
| 2026-02-20 | Thornal Kevin R | +27,385 | - | - |
| 2026-02-20 | Tornos Ivan | +65,103 | - | - |
| 2026-02-20 | Tornos Ivan | -15,996 | - | - |
| 2026-02-20 | Tornos Ivan | -8,846 | $98.62 | $872,393 |
| 2026-02-20 | Tornos Ivan | +15,996 | - | - |
| 2026-02-20 | Stellato Paul A | +4,651 | - | - |
| 2026-02-20 | Stellato Paul A | +2,842 | - | - |
| 2026-02-20 | Stellato Paul A | -701 | - | - |
| 2026-02-20 | Stellato Paul A | -362 | $98.62 | $35,700 |
| 2026-02-20 | Stellato Paul A | +701 | - | - |
| 2026-02-20 | Yi Sang | +9,043 | - | - |
| 2026-02-20 | Yi Sang | -2,382 | - | - |
| 2026-02-20 | Yi Sang | +2,382 | - | - |
| 2026-02-20 | Upadhyay Suketu | +21,701 | - | - |
| 2026-02-20 | Upadhyay Suketu | -5,445 | - | - |
| 2026-02-20 | Upadhyay Suketu | -2,446 | $98.62 | $241,225 |
| 2026-02-20 | Upadhyay Suketu | +5,445 | - | - |
| 2026-02-20 | Phipps Chad F | +9,818 | - | - |
| 2026-02-20 | Phipps Chad F | -2,246 | - | - |
| 2026-02-20 | Phipps Chad F | -942 | $98.62 | $92,900 |
| 2026-02-20 | Phipps Chad F | +2,246 | - | - |
| 2026-02-19 | VAN ZUILEN WILFRED | +4,843 | - | - |
| 2026-02-19 | Winkler Lori | +3,935 | - | - |
| 2026-02-19 | Tornos Ivan | +24,436 | - | - |
| 2026-02-19 | Stellato Paul A | +1,363 | - | - |
| 2026-02-19 | Yi Sang | +7,050 | - | - |
| 2026-02-19 | Upadhyay Suketu | +10,217 | - | - |
| 2026-02-19 | Phipps Chad F | +4,692 | - | - |
| 2026-02-12 | Yi Sang | -1,000 | $96.49 | $96,490 |
| 2025-12-31 | Shapiro Louis | +152 | - | - |
| 2025-12-31 | Kurdikar Devdatt | +152 | - | - |
| 2025-12-31 | Kolli Sreelakshmi | +173 | - | - |
| 2025-12-31 | Hilado Maria Teresa | +374 | - | - |
| 2025-12-31 | Farrell Michael J. | +415 | - | - |
| 2025-12-31 | HAGEMANN ROBERT | +304 | - | - |
| 2025-12-31 | HIGGINS ARTHUR J | +304 | - | - |
| 2025-11-28 | Winkler Lori | -123 | - | - |
| 2025-11-28 | Winkler Lori | -57 | - | - |
| 2025-11-28 | Winkler Lori | -123 | $97.52 | $11,995 |
| 2025-11-28 | Winkler Lori | +123 | - | - |
| 2025-11-28 | Winkler Lori | -57 | $97.52 | $5,559 |
| 2025-11-28 | Winkler Lori | +57 | - | - |
| 2025-11-10 | Upadhyay Suketu | -10,632 | - | - |
| 2025-11-10 | Upadhyay Suketu | -4,731 | $87.73 | $415,051 |
| 2025-11-10 | Upadhyay Suketu | +10,632 | - | - |
| 2025-10-24 | Upadhyay Suketu | +10,632 | - | - |